Scholars Central

Case reportPublished 13 Jan 2023

A Rare Case of Pulmonary Anaplastic Lymphoma Kinase Positive Signet Ring Cell Carcinoma in A Japanese Male

Authors: Yuji Ohtsuki, Shunsuke Fukino, Takashi Ohno, Wataru Kodama, Yasushi Horie

1Department of Diagnostic Pathology, Tottori Kousei Hospital, Higashi-Showa Machi, Kurayoshi, Tottori, Japan; 2Department of Thoracic Surgery, Tottori Kousei Hospital, Higashi-Showa Machi, Kurayoshi, Tottori, Japan; 3Department of Diagnostic Pathology, Tottori University Hospital, Yonago, Tottori, Japan

Journal of Oncology Research and Treatment

Volume 8 · Issue 1 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Here, we report an exceedingly rare case of pulmonary cancer, composed of more than 70% Signet Ring Cells (SRC) in a Japanese male in his early 70s. Computed tomography detected the tumor shadow in the right lower lobe of the lung revealing a size of 1.1 cm × 0.7 cm × 0.7 cm. The SRCs were positive for Cytokeratin 7 (CK7), Thyroid Transcription Factor-1 (TTF-1), and Anaplastic Lymphoma Kinase (ALK). The presence of SRC indicates one of the worst prognostic factors for patients with pulmonary cancer, based on the statistical analysis of ALK-positive cases. The possibility of the 5 year survival was reported to be only 11%. The anti-ALK inhibitor crizotinib has been applied in practical clinical therapy and obtained partial remission. However, drug resistance is exhibited in SRC cancer. This is a significant concern for future clinical application of the drug for this type of lung cancer that exhibits poor prognosis. However in our report, no recurrence or distant metastasis was detected in the patient 15 months after operation despite not using crizotinib. Finally, the composition of SRC in lung cancer should be considered for the patient’s prognosis, especially when ALK-positivity is detected.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Oncology Research and Treatment.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Oncology Research and Treatment
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Yuji Ohtsuki”
  • BylineArticles whose byline prints “Shunsuke Fukino”
  • BylineArticles whose byline prints “Takashi Ohno”
  • BylineArticles whose byline prints “Wataru Kodama”
  • BylineArticles whose byline prints “Yasushi Horie”